Suchergebnisse - "Quashie, Peter K"

PubPharm (9)

1

Progressive emergence of an S153F plus R263K combination of integrase mutations in the proviral DNA of one individual successfully treated with dolutegravir

enthalten in: The Journal of antimicrobial chemotherapy | 2021

von Pham, H. | Alves, B. | Yoo, S. | +7

2

The R263K substitution in HIV-1 subtype C is more deleterious for integrase enzymatic function and viral replication than in subtype B

enthalten in: AIDS (London, England) | 2015

von Mesplède, T. | Quashie, P. | Hassounah, S. | +5

3

Addition of E138K to R263K in HIV integrase increases resistance to dolutegravir, but fails to restore activity of the HIV integrase enzyme and viral replication capacity

enthalten in: The Journal of antimicrobial chemotherapy | 2014

von Mesplède, T. | Osman, N. | Wares, M. | +6

4

Effect of HIV-1 integrase resistance mutations when introduced into SIVmac239 on susceptibility to integrase strand transfer inhibitors

enthalten in: Journal of virology | 2014

von Hassounah, S. | Mesplède, T. | Quashie, P. | +3

5

Resistance mutations against dolutegravir in HIV integrase impair the emergence of resistance against reverse transcriptase inhibitors

enthalten in: AIDS (London, England) | 2014

von Oliveira, M. | Mesplède, T. | Quashie, P. | +2

6

The M50I polymorphic substitution in association with the R263K mutation in HIV-1 subtype B integrase increases drug resistance but does not restore viral replicative fitness

enthalten in: Retrovirology | 2014

von Wares, M. | Mesplède, T. | Quashie, P. | +3

7

Biochemical analysis of the role of G118R-linked dolutegravir drug resistance substitutions in HIV-1 integrase

enthalten in: Antimicrobial agents and chemotherapy | 2013

von Quashie, P. | Mesplède, T. | Han, Y. | +6

ErratumIn: Antimicrob Agents Chemother. 2014 Jan;58(1):633

8

Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure

enthalten in: Retrovirology | 2013

von Mesplède, T. | Quashie, P. | Osman, N. | +6

9

Characterization of the R263K mutation in HIV-1 integrase that confers low-level resistance to the second-generation integrase strand transfer inhibitor dolutegravir

enthalten in: Journal of virology | 2012

von Quashie, P. | Mesplède, T. | Han, Y. | +5

1
[1]